Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Nitric oxide synthesis and TNF-alpha secretion in RAW 264.7 macrophages: mode of action of a fermented papaya preparation.

Rimbach G, Park YC, Guo Q, Moini H, Qureshi N, Saliou C, Takayama K, Virgili F, Packer L.

Life Sci. 2000 Jun 30;67(6):679-94.

PMID:
12659174
2.

Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.

Zhou R, Zheng SX, Tang W, He PL, Li XY, Yang YF, Li YC, Geng JG, Zuo JP.

J Pharmacol Exp Ther. 2006 Jan;316(1):121-8. Epub 2005 Sep 15.

4.

Effects of 6-formylpterin, a xanthine oxidase inhibitor and a superoxide scavenger, on production of nitric oxide in RAW 264.7 macrophages.

Mori H, Arai T, Hirota K, Ishii H, Endo N, Makino K, Fukuda K.

Biochim Biophys Acta. 2000 Mar 6;1474(1):93-9.

PMID:
10699495
6.
8.

Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7.

Kobuchi H, Droy-Lefaix MT, Christen Y, Packer L.

Biochem Pharmacol. 1997 Mar 21;53(6):897-903.

PMID:
9113109
10.

Nitric oxide and tumor necrosis factor-alpha production by oleanolic acid via nuclear factor-kappaB activation in macrophages.

Choi CY, You HJ, Jeong HG.

Biochem Biophys Res Commun. 2001 Oct 19;288(1):49-55.

PMID:
11594750
11.

The effects of lidocaine on nitric oxide production from an activated murine macrophage cell line.

Shiga M, Nishina K, Mikawa K, Obara H.

Anesth Analg. 2001 Jan;92(1):128-33.

PMID:
11133614
12.

Macrophages enhance the radiosensitizing activity of lipid A: a novel role for immune cells in tumor cell radioresponse.

De Ridder M, Verovski VN, Darville MI, Van Den Berge DL, Monsaert C, Eizirik DL, Storme GA.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):598-606.

PMID:
15380597
13.

Suppression of tumor necrosis factor-alpha and inducible nitric oxide synthase gene expression by THI 52, a new synthetic naphthyl-benzylisoquinoline alkaloid.

Kang YJ, Lee BK, Lee YS, Seo HG, Park MK, Kim HJ, Pyo HS, Chong WS, Jung HJ, Yun-Choi HS, Lee DH, Chang KC.

Biochem Pharmacol. 2003 Feb 1;65(3):457-64.

PMID:
12527339
14.

Inhibitory effect of sulphated polysaccharide porphyran on nitric oxide production in lipopolysaccharide-stimulated RAW264.7 macrophages.

Jiang Z, Hama Y, Yamaguchi K, Oda T.

J Biochem. 2012 Jan;151(1):65-74. doi: 10.1093/jb/mvr115. Epub 2011 Oct 5.

PMID:
21976706
16.

Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages.

Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman WA, Wood ER, Smith GK, McDonald B, Bachus KE, et al.

Blood. 1995 Aug 1;86(3):1184-95.

18.

Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.

Kang JS, Jeon YJ, Kim HM, Han SH, Yang KH.

J Pharmacol Exp Ther. 2002 Jul;302(1):138-44.

19.

The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.

Lee HJ, Oh YK, Rhee M, Lim JY, Hwang JY, Park YS, Kwon Y, Choi KH, Jo I, Park SI, Gao B, Kim WH.

J Mol Biol. 2007 Jun 15;369(4):967-84. Epub 2007 Apr 1.

PMID:
17475277
20.

Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture.

Reykdal S, Abboud C, Liesveld J.

Exp Hematol. 1999 Mar;27(3):441-50.

PMID:
10089906

Supplemental Content

Support Center